Identification of Risk Factors for Diabetes Type 2 and Components of Pharmacists' Interventions in Community Pharmacy Setting: A Serbian Pilot Study

被引:1
|
作者
Tasic, Ljiljana [1 ]
Pesic, Vukica Kocic [2 ]
机构
[1] Univ Belgrade, Fac Pharm, Dept Social Pharm & Pharmaceut Legislat, V Stepe Str 450, Belgrade 11221, Serbia
[2] ADOC Co, Dept Res & Qual, Belgrade, Serbia
关键词
Prevention; Type 2 Diabetes Mellitus; Pharmacists' Intervention; Complex intervention; Community Pharmacy; SYSTEMATIC REVIEWS; PROGRAM; IMPACT; CARE; MANAGEMENT; SERVICES; GLUCOSE;
D O I
10.5530/ijper.50.1.12
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Prevention of Type 2 diabetes (T2D) is clinical service useful to implement on community pharmacy settings (CP). The objectives of study were: to determine the risk factors for T2D in adults visiting a community pharmacy; to determine and describe component of pharmacists' interventions (PI) focusing on feasibility of complex intervention (CI). A cross-sectional study design and conducted (January 2010 to June 2011) on 20 CP in Serbia. Adult population was enrolled (304 patients). The pharmacist trained for implementation of complex PI (screening and counseling session). The national Questionnaire for T2D risk estimation was used for screening and Intervention check list was design and used for process of counseling. The DEPICT (Descriptive Elements of Pharmacist Intervention Characterization Tool) was used to describe the component of CI. High and very high risk score was estimated in age group 45-54 (10.80%) forward in age group 55-64 (9.60%); into the cohort below 45 year the 59 adults has low T2D risk score. The average value of PI/per patients was 4.02. From the eight domain/component (operational descriptor in DEPICT) the main component are 'education and counseling' with four type (items) of intervention performed in counseling session. As a conclusion, the pharmacists in CP detected and scoring risk of T2D in Serbian adults' population. The number and type of PI in counseling session adequate to participants clinical profile. Feasibility of the CI within the CP in Serbia was proved. For the outcomes measurements and impact of PI, a proper endpoint and follow-up study design should be conduct.
引用
收藏
页码:90 / 102
页数:13
相关论文
共 50 条
  • [41] Findings from Community-Based Screenings for Type 2 Diabetes Mellitus in at Risk Communities in Cape Town, South Africa: A Pilot Study
    Hill, Jillian
    Peer, Nasheeta
    Jonathan, Deborah
    Mayige, Mary
    Sobngwi, Eugene
    Kengne, Andre Pascal
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (08)
  • [42] Cardiovascular Disease Risk Factors, Type 2 Diabetes Mellitus, and the Framingham Heart Study
    Fox, Caroline S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2010, 20 (03) : 90 - 95
  • [43] Reproductive factors, genetic susceptibility and risk of type 2 diabetes: A prospective cohort study
    Fan, Gaojie
    Liu, Qing
    Bi, Jianing
    Qin, Xiya
    Fang, Qing
    Luo, Fei
    Huang, Xiaofeng
    Li, Heng
    Wang, Youjie
    Song, Lulu
    DIABETES & METABOLISM, 2024, 50 (05)
  • [44] Risk factors associated with progression to referable retinopathy: a type 2 diabetes mellitus cohort study in the Republic of Ireland
    Smith, J. J.
    Wright, D. M.
    Scanlon, P.
    Lois, N.
    DIABETIC MEDICINE, 2020, 37 (06) : 1000 - 1007
  • [45] Setting Single or Multiple Goals for Diet and Physical Activity Behaviors Improves Cardiovascular Disease Risk Factors in Adults With Type 2 Diabetes: A Pragmatic Pilot Randomized Trial
    Swoboda, Christine M.
    Miller, Carla K.
    Wills, Celia E.
    DIABETES EDUCATOR, 2016, 42 (04) : 429 - 443
  • [46] Development and Feasibility of an App to Decrease Risk Factors for Type 2 Diabetes in Hispanic Women With Recent Gestational Diabetes (Hola Bebe, Adios Diabetes): Pilot Pre-Post Study
    Seely, Ellen W.
    Weitzman, Patricia Flynn
    Cortes, Dharma
    Vicente, Sara Romero
    Levkoff, Sue E.
    JMIR FORMATIVE RESEARCH, 2020, 4 (12)
  • [47] Risk factors and outcomes of anxiety symptom trajectories in type 2 diabetes: the Fremantle Diabetes Study Phase II
    Whitworth, S. R.
    Bruce, D. G.
    Starkstein, S. E.
    Davis, T. M. E.
    Skinner, T. C.
    Davis, W. A.
    Bucks, R. S.
    DIABETIC MEDICINE, 2020, 37 (10) : 1688 - 1695
  • [48] Associations between weight loss history and factors related to type 2 diabetes risk in the Stop Diabetes study
    Halali, F.
    Lapvetelainen, A.
    Aittola, K.
    Mannikko, R.
    Tilles-Tirkkonen, T.
    Jarvela-Reijonen, E.
    Absetz, P.
    Kolehmainen, M.
    Schwab, U.
    Lindstrom, J.
    Lakka, T. A.
    Pihlajamaki, J.
    Karhunen, L.
    INTERNATIONAL JOURNAL OF OBESITY, 2022, 46 (05) : 935 - 942
  • [49] Assessing Type 2 Diabetes Risk in the Post-Pandemic Era: A Pharmacy-Led FINDRISC Screening Study
    Bell, Victoria
    Rodrigues, Ana Rita
    Costa, Vera
    Dias, Catarina
    Alpalhao, Marcia
    Martins, Ines
    Forrester, Mario
    LIFE-BASEL, 2024, 14 (12):
  • [50] Prevalence and Risk Factors of Chronic Kidney Disease inPatients With Type 2 Diabetes in China:Cross-Sectional Study
    Shi, Lixin
    Xue, Yaoming
    Yu, Xuefeng
    Wang, Yangang
    Hong, Tianpei
    Li, Xiaoying
    Ma, Jianhua
    Zhu, Dalong
    Mu, Yiming
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2024, 10